Trial intelligence / Profile preview

Pioglitazone effects on inflammation in obese non-diabetic patients

NCT01161394Phase 4Completed

Sponsor
University at Buffalo
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pioglitazone in obesity, sponsored by University at Buffalo. Status: completed.

02

Drugs

pioglitazone
03

Conditions

obesity

Beyond the preview

Go deeper on NCT01161394.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01161394.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call